"Metastatic melanoma" trang 1 - tải miễn phí từ tailieunhanh
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): A retrospective cohort quality improvement study to reduce the morbidity rates

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): A retrospective cohort quality improvement study to reduce the morbidity rates
9    55    1
A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival

A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival
15    4    1
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma

Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma
7    39    1
Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis

Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis
11    69    1
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: A population-based cohort study in Ontario, Canada

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: A population-based cohort study in Ontario, Canada
10    87    0
An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines

An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines
13    69    0
Autoimmune comorbidities in patients with metastatic melanoma: A retrospective analysis of us claims data

Autoimmune comorbidities in patients with metastatic melanoma: A retrospective analysis of us claims data
9    55    1
Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review
5    34    1
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report
5    41    1
Case series: Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma

Case series: Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma
4    28    1
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
14    30    1
Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma

Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma
4    54    1
The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
10    23    1
Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: A case series

Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: A case series
5    1    1
Management of metastatic melanoma in Texas: Disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors

Management of metastatic melanoma in Texas: Disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors
11    1    1
A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
5    66    1
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: An observational cohort study in Denmark

The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: An observational cohort study in Denmark
11    60    1
GNAQ mutation in a patient with metastatic mucosal melanoma

GNAQ mutation in a patient with metastatic mucosal melanoma
4    47    1
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    26    1
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern

Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
16    6    1